Targeted Clinical AI Eysz focuses on biomarker-based tools and AI software to assist clinicians in diagnosing and managing brain disorders, starting with epilepsy, ADHD, and mood. This presents an opportunity to position advanced analytics, cloud-based processing, and clinician-friendly dashboards as scalable enhancements to their diagnostic workflow.

Eye-Tracking Data Their AI solution analyzes passive eye movements from compatible eye-tracking systems to capture seizure burden and cognitive side effects. Sales conversations can emphasize hardware-agnostic data integration, compatible device partnerships, and expanded data capture features to broaden adoption.

Funding & Growth With revenue in the low millions and a funded total around several million, Eysz is likely seeking strategic partnerships, additional investment, or customer pilots to accelerate product development and market penetration in neurology-focused care settings.

Clinical Workflow Fit The emphasis on delivering actionable data to clinicians signals a need for seamless EHR and workflow integrations, secure data handling, and regulatory-compliant solutions. Propose turnkey integration services and protected data pipelines to minimize adoption barriers.

Early-Stage Expansion Given their small team and recent multi-year press coverage, opportunities exist in co-development, OEM partnerships, and pilot programs with larger medical device distributors or telehealth platforms to scale reach and validate outcomes in real-world settings.